Travel distance and stereotactic body radiotherapy for localized prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Laparoscopy
  • Nephrectomy
  • Robotic Surgical Procedures

abstract

  • Definitive prostate SBRT use increased more than 3-fold since 2004, with a significant increase in use coinciding with early reports of short-term efficacy. Long-distance travel for treatment was associated with greater than twice the odds of receipt of definitive prostate SBRT compared with short-distance travel, suggesting that treatment decisions with unknown long-term clinical implications may be strongly driven by sociodemographic factors. Cancer 2018;124:1141-9. © 2017 American Cancer Society.

publication date

  • March 15, 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.31190

PubMed ID

  • 29231964

Additional Document Info

start page

  • 1141

end page

  • 1149

volume

  • 124

number

  • 6